Northleaf Venture Catalyst Fund completes USD300m investment program with USD15m commitment to Lumira Capital
Northleaf Venture Catalyst Fund (NVCF) has made a USD15 million lead commitment to Lumira Capital IV, a late-stage venture capital fund investing in high-potential biopharmaceutical and medical device companies. With the closing of this investment, Northleaf has completed the NVCF investment program, with a total of USD300 million committed to